Reproductive Justice
More on Reproductive Justice
WASHINGTON – Today, Congresswoman Ayanna Pressley (MA-07), Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force, issued the following statement on the Supreme Court’s inaction on Texas’ restrictive abortion law.
WASHINGTON, D.C.– Today Congresswoman Ayanna Pressley, Chair of the Pro-Choice Caucus’s Abortion Rights, Rep. Judy Chu (D-CA), Rep. Lois Frankel (D-FL), and Rep. Veronica Escobar (D-TX), and U.S. Senators Richard Blumenthal (D-CT) and Tammy Baldwin (D-WI) issued a statement in reaction to the Supreme Court’s decision to allow a restrictive Texas anti-abortion law to take effect.
WASHINGTON – Today, Congresswoman Ayanna Pressley, Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force and Oversight & Reform Committee member; Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform; Rep. Diana DeGette, Co-Chair of the Pro-Choice Caucus; and Rep. Barbara Lee, Co-Chair of the Pro-Choice Caucus announced a resolution in support of equitable, science-based policies governing access to medication abortion care.
WASHINGTON – Congresswoman Ayanna Pressley (MA-07) and U.S. Senator Tammy Duckworth (D-IL) today introduced legislation to raise awareness about pregnancy loss and establish new paid leave benefits for workers experiencing painful challenges while seeking to grow their family.
WASHINGTON – Today, Congresswoman Ayanna Pressley (MA-07) issued the following statement on President Biden’s call to eliminate the Hyde Amendment in his Fiscal Year 2022 budget.
“I applaud President Biden’s decision to honor his commitment to strike the Hyde Amendment from his Fiscal Year 2022 presidential budget proposal.
WASHINGTON – Today, Congresswoman Ayanna Pressley (MA-07), Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force, and House Oversight Committee Chairwoman Carolyn B. Maloney, issued the following statement in response to the Food and Drug Administration (FDA) announcing an evidence-based review of the in-person dispensing requirement for the medication abortion drug mifepristone: